Department of Lung Diseases and Tuberculosis, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
Department of Respiratory Medicine, Allergology and Pulmonary Oncology, Poznań University of Medical Sciences, Poznań, Poland.
Adv Med Sci. 2023 Sep;68(2):482-490. doi: 10.1016/j.advms.2023.10.009. Epub 2023 Nov 7.
Bronchoalveolar lavage (BAL) procedure is a useful tool in the diagnosis of patients with interstitial lung disease (ILD) and is helpful in clinical research of chronic obstructive pulmonary disease (COPD) patients. Still little is known about predictors of poor BAL salvage. The trial aims to find the most efficient way to improve BAL recovery.
Our study is a prospective, multicenter, international, two-arm randomized controlled trial. We aim to obtain BAL samples from a total number of 300 patients: 150 with ILD and 150 with COPD to achieve a statistical power of 80 %. Patients with initial BAL salvage <60 % will be randomized into the non-invasive ventilation (NIV) or continuous positive airway pressure (CPAP) arm. The NIV and CPAP will be set according to the study protocol. The influence on BAL salvage will be assessed in terms of BAL volume and content. Multivariable analysis of the additional test results to determine predictors for low BAL recovery will be conducted. In a study subgroup of approximately 20 patients per specific disease, a metabolomic assessment of exhaled air condensate will be performed. All procedures will be assessed in terms of the patient's safety. The trial was registered on clinicaltrials.gov (ID# NCT05631132). Interested experienced centers are invited to join the research group by writing to the corresponding author.
The results of our prospective study will address the currently unsolved problem of how to increase BAL salvage in patients with pulmonary diseases without increasing the risk of respiratory failure exacerbation.
支气管肺泡灌洗(BAL)程序是诊断间质性肺疾病(ILD)患者的有用工具,有助于慢性阻塞性肺疾病(COPD)患者的临床研究。尽管目前对于影响 BAL 回收的预测因素知之甚少。该试验旨在寻找提高 BAL 回收率的最有效方法。
我们的研究是一项前瞻性、多中心、国际、双臂随机对照试验。我们的目标是从总共 300 名患者中获得 BAL 样本:150 名ILD 患者和 150 名 COPD 患者,以达到 80%的统计效力。初始 BAL 回收率<60%的患者将被随机分为无创通气(NIV)或持续气道正压通气(CPAP)组。NIV 和 CPAP 将根据研究方案设置。将根据 BAL 体积和内容评估对 BAL 回收的影响。将进行多变量分析以确定低 BAL 恢复的附加测试结果的预测因子。在每个特定疾病的大约 20 名患者的研究亚组中,将对呼出气冷凝物进行代谢组学评估。所有程序都将根据患者的安全性进行评估。该试验已在 clinicaltrials.gov 上注册(ID#NCT05631132)。有兴趣的经验丰富的中心可通过致信相应作者加入研究小组。
我们前瞻性研究的结果将解决目前尚未解决的问题,即如何在不增加呼吸衰竭恶化风险的情况下增加肺病患者的 BAL 回收率。